Report for Matosevic A

General

Full name : Matosevic Ana

First name : Ana

Mail : Institute for Medical Research and Occupational Health, Ksaverska cesta 2, Zagreb

Zip Code :

City :

Country : Croatia

Email : amatosevic@imi.hr

Phone :

Fax :

Website :

Directory :

References (6)

Title : Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease - Matosevic_2023_Chem.Biol.Interact_14ChEPon_382_110620
Author(s) : Matosevic A , Opsenica DM , Spasic M , Marakovic N , Zandona A , Zunec S , Bartolic M , Kovarik Z , Bosak A
Ref : Chemico-Biological Interactions , 382 :110620 , 2023
Abstract : Matosevic_2023_Chem.Biol.Interact_14ChEPon_382_110620
ESTHER : Matosevic_2023_Chem.Biol.Interact_14ChEPon_382_110620
PubMedSearch : Matosevic_2023_Chem.Biol.Interact_14ChEPon_382_110620
PubMedID: 37406982

Title : Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease - Matosevic_2022_Pharmaceuticals.(Basel)_15_
Author(s) : Matosevic A , Knezevic A , Zandona A , Marakovic N , Kovarik Z , Bosak A
Ref : Pharmaceuticals (Basel) , 15 : , 2022
Abstract : Matosevic_2022_Pharmaceuticals.(Basel)_15_
ESTHER : Matosevic_2022_Pharmaceuticals.(Basel)_15_
PubMedSearch : Matosevic_2022_Pharmaceuticals.(Basel)_15_
PubMedID: 36297332

Title : Synthesis, Biological Evaluation and Machine Learning Prediction Model for Fluorinated Cinchona Alkaloid-Based Derivatives as Cholinesterase Inhibitors - Ramic_2022_Pharmaceuticals.(Basel)_15_
Author(s) : Ramic A , Matosevic A , Debanic B , Mikelic A , Primozic I , Bosak A , Hrenar T
Ref : Pharmaceuticals (Basel) , 15 : , 2022
Abstract : Ramic_2022_Pharmaceuticals.(Basel)_15_
ESTHER : Ramic_2022_Pharmaceuticals.(Basel)_15_
PubMedSearch : Ramic_2022_Pharmaceuticals.(Basel)_15_
PubMedID: 36297327

Title : 4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer's Disease - Komatovic_2022_Pharmaceutics_14_
Author(s) : Komatovic K , Matosevic A , Terzic-Jovanovic N , Zunec S , Segan S , Zlatovic M , Marakovic N , Bosak A , Opsenica DM
Ref : Pharmaceutics , 14 : , 2022
Abstract : Komatovic_2022_Pharmaceutics_14_
ESTHER : Komatovic_2022_Pharmaceutics_14_
PubMedSearch : Komatovic_2022_Pharmaceutics_14_
PubMedID: 35745878

Title : Quinuclidine-Based Carbamates as Potential CNS Active Compounds - Matosevic_2021_Pharmaceutics_13_
Author(s) : Matosevic A , Radman Kastelic A , Mikelic A , Zandona A , Katalinic M , Primozic I , Bosak A , Hrenar T
Ref : Pharmaceutics , 13 : , 2021
Abstract : Matosevic_2021_Pharmaceutics_13_
ESTHER : Matosevic_2021_Pharmaceutics_13_
PubMedSearch : Matosevic_2021_Pharmaceutics_13_
PubMedID: 33804719

Title : Carbamate group as structural motif in drugs: a review of carbamate derivatives used as therapeutic agents - Matosevic_2020_Arh.Hig.Rada.Toksikol_71_285
Author(s) : Matosevic A , Bosak A
Ref : Arh Hig Rada Toksikol , 71 :285 , 2020
Abstract : Matosevic_2020_Arh.Hig.Rada.Toksikol_71_285
ESTHER : Matosevic_2020_Arh.Hig.Rada.Toksikol_71_285
PubMedSearch : Matosevic_2020_Arh.Hig.Rada.Toksikol_71_285
PubMedID: 33410773